How cell & gene therapy startups can warm up to investors in this “biotech nuclear winter” May 9, 2022
Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers May 5, 2022
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi May 2, 2022
Wellframe Addresses the Caregiver Crises Through an Expanded Program Aimed to Assist 250,000 Members by 2025 April 28, 2022
1upHealth Announces SQL on FHIR® to Easily Ask Hard Questions of Healthcare FHIR® Data and Make Timely Real-World Decisions April 27, 2022